Colgate-Palmolive (NYSE:CL) SVP John J. Huston sold 14,000 shares of the company’s stock in a transaction on Friday, February 9th. The shares were sold at an average price of $69.44, for a total value of $972,160.00. Following the completion of the transaction, the senior vice president now owns 100,508 shares of the company’s stock, valued at $6,979,275.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Colgate-Palmolive (NYSE:CL) opened at $69.62 on Thursday. The company has a debt-to-equity ratio of 24.42, a quick ratio of 0.34 and a current ratio of 0.47. Colgate-Palmolive has a 12 month low of $67.52 and a 12 month high of $77.91. The stock has a market capitalization of $61,730.80, a price-to-earnings ratio of 24.50, a price-to-earnings-growth ratio of 2.60 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.75. Colgate-Palmolive had a return on equity of 1,716.69% and a net margin of 13.10%. The firm had revenue of $3.89 billion during the quarter, compared to analyst estimates of $3.92 billion. During the same period in the prior year, the company posted $0.75 earnings per share. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. equities analysts anticipate that Colgate-Palmolive will post 3.18 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, February 15th. Shareholders of record on Tuesday, January 23rd will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Monday, January 22nd. This represents a $1.60 annualized dividend and a yield of 2.30%. Colgate-Palmolive’s dividend payout ratio is currently 70.18%.

A number of institutional investors have recently added to or reduced their stakes in CL. Jacobi Capital Management LLC increased its stake in shares of Colgate-Palmolive by 125.5% in the third quarter. Jacobi Capital Management LLC now owns 1,443 shares of the company’s stock valued at $104,000 after buying an additional 803 shares in the last quarter. Virtue Capital Management LLC acquired a new stake in shares of Colgate-Palmolive in the fourth quarter valued at $104,000. Krilogy Financial LLC increased its stake in shares of Colgate-Palmolive by 23.0% in the second quarter. Krilogy Financial LLC now owns 1,547 shares of the company’s stock valued at $115,000 after buying an additional 289 shares in the last quarter. Captrust Financial Advisors acquired a new stake in shares of Colgate-Palmolive in the second quarter valued at $122,000. Finally, AlphaMark Advisors LLC increased its stake in shares of Colgate-Palmolive by 1.5% in the second quarter. AlphaMark Advisors LLC now owns 1,698 shares of the company’s stock valued at $126,000 after buying an additional 25 shares in the last quarter. Hedge funds and other institutional investors own 72.85% of the company’s stock.

A number of research analysts recently commented on CL shares. BNP Paribas lowered Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research note on Tuesday, January 30th. Morgan Stanley cut their target price on Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating for the company in a research note on Tuesday, October 31st. Zacks Investment Research lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday, October 25th. Jefferies Group cut their target price on Colgate-Palmolive from $79.00 to $76.00 and set a “hold” rating for the company in a research note on Monday, October 30th. Finally, Deutsche Bank started coverage on Colgate-Palmolive in a research note on Wednesday, December 13th. They issued a “hold” rating and a $75.00 target price for the company. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the stock. Colgate-Palmolive currently has an average rating of “Hold” and a consensus price target of $77.71.

ILLEGAL ACTIVITY NOTICE: “Insider Selling: Colgate-Palmolive (CL) SVP Sells 14,000 Shares of Stock” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.thecerbatgem.com/2018/02/15/insider-selling-colgate-palmolive-cl-svp-sells-14000-shares-of-stock.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.